Phibro Animal Health Corporation Class A Company Profile
NASDAQ: PAHCHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 38.30 0.00%
Phibro Animal Health at a glance
Phibro Animal Health Corporation Class A (NASDAQ: PAHC) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Teaneck, NJ. Phibro Animal Health is led by Mr. Daniel M. Bendheim J.D. and employs about 2,605 people. The company's shares have traded publicly since 2014.
At a market capitalization of $1.56 billion, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001069899, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Phibro Animal Health do?
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries. It sells its animal health and mineral nutrition products through local sales offices to integrated poultry, swine, and cattle producers, as well as through commercial animal feed manufacturers, wholesalers, and distributors. The company was formerly known as Philipp Brothers Chemicals, Inc. and changed its name to Phibro Animal Health Corporation in July 2003. Phibro Animal Health Corporation was incorporated in 1946 and is headquartered in Teaneck, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- Phibro Animal Health Corporation Class A
- Ticker
- NASDAQ: PAHC
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Daniel M. Bendheim J.D.
- Employees
- 2,605
- Headquarters
- Glenpointe Centre East, Teaneck, NJ, United States
- Phone
- 201 329 7300
- Website
- pahc.com
- IPO year
- 2014
- Market cap
- $1.56B
- SEC CIK
- 0001069899
- Latest annual report
- 10-K · Aug 26, 2026
Companies similar to Phibro Animal Health
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| KRSAKorsana Biosciences Inc. | 33.92 | +1.22% | $1.54B | vs PAHC |
| QUREuniQure N.V. | 22.59 | +0.22% | $1.57B | vs PAHC |
| INVAInnoviva Inc. | 21.21 | +1.63% | $1.53B | vs PAHC |
| ETONEton Pharmaceuticals Inc. | 55.21 | +0.84% | $1.58B | vs PAHC |
| RAREUltragenyx Pharmaceutical Inc. | 15.48 | +1.24% | $1.53B | vs PAHC |
| SNDXSyndax Pharmaceuticals Inc. | 16.99 | +0.53% | $1.52B | vs PAHC |
| STOKStoke Therapeutics Inc. | 24.74 | +3.30% | $1.60B | vs PAHC |
| KLRAKailera Therapeutics Inc. | 11.61 | +16.10% | $1.51B | vs PAHC |